Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00529061 · ClinicalTrials.gov registry record

Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])

A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Terminated
Registry status
3,640
Enrollment target

NCT00529061 is a clinical trial that was terminated before completion, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 3,640 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00529061 was terminated before completion, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

TERMINATED
Registry status
3,640 participants
Enrollment target

Study Summary

Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited blood disease that can cause intense pain episodes. The purpose of this study is to gather medical information from children and adults with SCD and establish a database so that researchers can contact people to participate in future SCD research studies.

Trial Details

FieldValue
Enrollment Target 3,640 participants
Start Date 2005-03
Est. Completion 2008-09

What the Registry Record Tells You About NCT00529061

The ClinicalTrials.gov registry entry for NCT00529061 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3,640 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00529061 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00529061 about?

NCT00529061 is a clinical study titled "Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])". Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited blood disease that can cause intense pain episodes. The purpose of this study is to gather medical information from children and adults with SCD and establish a database so that researchers can contact people to participate...

What is the current status of trial NCT00529061?

This trial is currently terminated. The enrollment target is 3,640 participants. The study started on 2005-03. Estimated completion is 2008-09.

Who is sponsoring clinical trial NCT00529061?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.